Health · 3 views
Treatment satisfaction higher for patients with rheumatoid arthritis choosing their own treatment
For patients with rheumatoid arthritis (RA), those choosing their own treatment have higher treatment satisfaction, better treatment retention and fewer reported adverse events, according to a study published online Oct. 27 in RMD Open .
AI Summary
A multicenter randomized trial of biologic‑DMARD‑naive rheumatoid arthritis patients found that individuals who selected their own therapy reported higher treatment satisfaction, better retention and fewer adverse events than those assigned a regimen. The study involved 102 participants who could choose between a subcutaneous tumor necrosis factor inhibitor and the oral Janus kinase inhibitor filgotinib, or be randomly allocated to one of those options. Results were published online on Oct. 27 in RMD Open.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Ultrathin optical coherence tomography endoscope could enable imaging during retinal surgeryContinue reading
- In the future, a blood test may be able to replace a biopsyContinue reading
- What Will the Midterms Mean for Healthcare?Continue reading
- Give us all a share of Rolls-Royce’s profits | Brief lettersContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow